Skip to content

A Study on Carpal tunnel syndrome for finding efficacy of Homoeopathic medicine

COMPARATIVE EVALUATION OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN CENTESIMAL AND FIFTY-MILLESIMAL POTENCIES ADMINISTERED BY PLUSSING METHOD IN THE MANAGEMENT OF CARPAL TUNNEL SYNDROME: A RANDOMIZED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109623
Enrollment
40
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G560- Carpal tunnel syndrome

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN CENTESIMAL POTENCY: INDIVIDUALIZED HOMOEOPATHIC MEDICINE SELECTED ACCORDING TO TOTALITY OF SYMPTOMS.CENTESIMAL POTENCY OF INDIVIDUALIZED MEDICINE

Sponsors

SHAMEEMA P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CASES WITH SYMPTOMS INCLUDING BURNING TINGLING OR NUMBNESS IN THE PALM THAT SPREADS TO THE FINGERS HAND WEAKNESS LIMITED MOBILITY AND A LOSS IN GRIP STRENGTH DIAGNOSED BY NERVE CONDUCTION STUDIES .

Exclusion criteria

Exclusion criteria: 1. PREGNANT OR LACTATING WOMEN. 2. CARPAL TUNNEL SYNDROME SECONDARY TO SYSTEMIC CONDITIONS SUCH AS DIABETES MELLITUS, RHEUMATOID ARTHRITIS, HYPOTHYROIDISM, OR OTHER METABOLIC OR INFLAMMATORY DISORDERS. 3. HISTORY OF PRIOR SURGICAL INTERVENTION FOR CARPAL TUNNEL SYNDROME, INCLUDING CARPAL TUNNEL RELEASE PROCEDURES. 4. HISTORY OF TRAUMA OR ORTHOPEDIC INJURY TO THE WRIST OR HAND, INCLUDING FRACTURES, DISLOCATIONS, OR LIGAMENT INJURIES, WHICH MAY AFFECT NERVE CONDUCTION OR SYMPTOMATOLOGY.

Design outcomes

Primary

MeasureTime frame
SYMPTOMATIC IMPROVEMENT ASSESSED BY CHANGE IN BOSTON CARPAL TUNNEL SYNDROME QUESTIONNAIRE (BCTQ) SCORES AND CHANGE IN CTS-6 EVALUATION TOOL SCORESTimepoint: MEASURED EVERY 2 TO 4 WEEK OR AS NEEDED FOR 16 WEEK FROM POINT OF ADMISSION OR FIRST CONSULTATION

Secondary

MeasureTime frame
THE DIFFERENCE IN EFFECT OF CENTESIMAL AND LM SCALE POTENCIES EVALUATED BY CHANGES IN THE SCORES OF ASSESSMENT PARAMETERS SUCH AS BOSTON CARPAL TUNNEL SYNDROME QUESTIONNAIRE, 6 ITEM CARPAL TUNNEL SYNDROME SYMPTOM SCALETimepoint: MEASURED AT BASE LINE AND END OF TREATMENT OR AFTER 16 WEEK

Countries

India

Contacts

Public ContactDR RITHESH B

GOVERNMENT HOMOEOPATHIC MEDICAL COLLEGE KOZHIKODE

ritheshb.dr@gmail.com9400111908

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026